Why the study?
Does HIV infection and antiretroviral therapy impact arterial stiffness and vasculature in adult Africans?
Does HIV infection and antiretroviral therapy impact arterial stiffness and vasculature in adult Africans?
This review highlights the significant burden of HIV and antiretroviral therapy on vascular health, specifically arterial stiffness and atherosclerosis, in adult Africans.
Aim: To review the impact of the human immunodeficiency virus and antiretroviral therapy on the vasculature. Objectives: This review seeks to identify the burden which the human immunodeficiency virus and antiretroviral therapy have on the vasculature. Method: Medline/PubMed and Google scholar were searched. There were over 100 publications reviewed. Some people who worked in similar fields were also contacted. The present review summarized current understanding of Human immunodeficiency virus, antiretroviral therapy and effect on the vasculature such as arterial stiffness. Atherosclerosis, endothelial dysfunction, the strengths and weaknesses of current testing strategies, and their potential applications in clinical research and patient care. The association of inflammatory biomarkers, blood pressure and ageing with arterial stiffness were also reviewed. Conclusion: Available literature shows that HIV and antiretroviral agents have a great impact on the vasculature and its progression.
No takes yet. Share an insight, caveat, or question.
Awotedu et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: